BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29423618)

  • 21. A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity.
    Jung DJ; Shin TH; Kim M; Sung CO; Jang SJ; Jeong GS
    Lab Chip; 2019 Sep; 19(17):2854-2865. PubMed ID: 31367720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-dimensional models for functional testing of keloid scars: In silico, in vitro, organoid, organotypic, ex vivo organ culture, and in vivo models.
    Lebeko M; Khumalo NP; Bayat A
    Wound Repair Regen; 2019 Jul; 27(4):298-308. PubMed ID: 30761660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment and application of gastric and gastric cancer organoids].
    Fan S; Yin J; Wang M; Guan W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1315-1320. PubMed ID: 30506544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response.
    Ramamoorthy P; Thomas SM; Kaushik G; Subramaniam D; Chastain KM; Dhar A; Tawfik O; Kasi A; Sun W; Ramalingam S; Gunewardena S; Umar S; Mammen JM; Padhye SB; Weir SJ; Jensen RA; Sittampalam GS; Anant S
    Cancer Res; 2019 Apr; 79(7):1681-1695. PubMed ID: 30674533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D Culture as a Clinically Relevant Model for Personalized Medicine.
    Fong ELS; Toh TB; Yu H; Chow EK
    SLAS Technol; 2017 Jun; 22(3):245-253. PubMed ID: 28277923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy.
    Nayak B; Balachander GM; Manjunath S; Rangarajan A; Chatterjee K
    Colloids Surf B Biointerfaces; 2019 Aug; 180():334-343. PubMed ID: 31075687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
    Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung cancer organoids, a promising model still with long way to go.
    Ma HC; Zhu YJ; Zhou R; Yu YY; Xiao ZZ; Zhang HB
    Crit Rev Oncol Hematol; 2022 Mar; 171():103610. PubMed ID: 35114386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of organoids in urological cancer research.
    Wang S; Gao D; Chen Y
    Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids.
    Takahashi N; Hoshi H; Higa A; Hiyama G; Tamura H; Ogawa M; Takagi K; Goda K; Okabe N; Muto S; Suzuki H; Shimomura K; Watanabe S; Takagi M
    Cells; 2019 May; 8(5):. PubMed ID: 31137590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research.
    Salinas-Vera YM; Valdés J; Pérez-Navarro Y; Mandujano-Lazaro G; Marchat LA; Ramos-Payán R; Nuñez-Olvera SI; Pérez-Plascencia C; López-Camarillo C
    Front Oncol; 2022; 12():826113. PubMed ID: 35692756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational applications of adult stem cell-derived organoids.
    Drost J; Clevers H
    Development; 2017 Mar; 144(6):968-975. PubMed ID: 28292843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
    Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
    Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-Clinical In Vitro Models Used in Cancer Research: Results of a Worldwide Survey.
    Martinez-Pacheco S; O'Driscoll L
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal Cancer Patient-Derived 2D and 3D Models Efficiently Recapitulate Inter- and Intratumoral Heterogeneity.
    Zhao Y; Zhang B; Ma Y; Zhao F; Chen J; Wang B; Jin H; Zhou F; Guan J; Zhao Q; Wang H; Liu Q; Zhao F; Wang X
    Adv Sci (Weinh); 2022 Aug; 9(22):e2201539. PubMed ID: 35652270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards manufacturing of human organoids.
    Ashok A; Choudhury D; Fang Y; Hunziker W
    Biotechnol Adv; 2020; 39():107460. PubMed ID: 31626951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment.
    Tosca EM; Ronchi D; Facciolo D; Magni P
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional models: a novel approach for lymphoma research.
    Rossi M; Alviano F; Righi S; Sabattini E; Agostinelli C
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):753-765. PubMed ID: 35091834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.